Skip to main content

Fresenius Medical Care Ag ADR(FMS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low22.53
Day High22.78
Open:22.68
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Barclays
Tipranks
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care Sets May 21, 2026 AGM With Dividend and New Buyback Mandate on Agenda
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG
Tipranks
J.P. Morgan Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Barclays Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Kepler Capital
Tipranks
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Jefferies Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care Signals Strong 2025, Tough 2026
Tipranks
Analysts Conflicted on These Healthcare Names: Day One Biopharmaceuticals (DAWN), Fresenius Medical Care (FMS) and BridgeBio Pharma (BBIO)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fresenius Medical Care (FMS), BridgeBio Pharma (BBIO) and Globus Medical (GMED)
Tipranks
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care Files 2025 Form 20-F with U.S. SEC
Tipranks
UBS Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Jefferies
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan
Tipranks
Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
UBS Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Barclays Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Kepler Capital
Tipranks
Fresenius Medical Care AG & Co. KGaA (0H9X) was downgraded to a Hold Rating at Goldman Sachs
Tipranks
UBS Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Zacks Investment Research
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Tipranks
J.P. Morgan Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Tipranks
Fresenius Medical Care Accelerates Second Tranche of €1 Billion Share Buyback
Tipranks
Fresenius Medical Care Appoints New Global Chief Medical Officer

Profile

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.